Is AstraZeneca a Buy After Share Price Jump?
Pharmaceutical giant AstraZeneca AZN is making a big play for US investors, and some say, turning its back on Britain. Will the bid for American dollars – and its pipeline of drugs – boost AstraZeneca’s stock?
AstraZeneca recently raised eyebrows – and its stock price – when it an announced it will list shares directly on the New York Stock Exchange.
Will AstraZeneca Delist From London?
Since the news of the listing plan, AstraZeneca stock has jumped 16% and its shares are now up 24% this year. That means AstraZeneca stock is on track for its best performance since 2022.
Though it will retain listings in both London and Stockholm, the move is considered a blow to London.
Investors are concerned that AstraZeneca’s decision could…
